Bodal Chemicals Limited (BODALCHEM) AI Stock Analysis

• Market Cap: ₹7.87B
• Dividend Yield: 0.17%
• Average Volume (3M): 20.82K
• Price to Earnings (P/E): 26.9
• Beta (1Y): 1.48
• Revenue Growth: 19.75%
• EPS Growth: 845.31%
• Country: IN
• Employees: 2,133
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 0.76
• Shares Outstanding: 125,944,060
• 10 Day Avg. Volume: 24,527
• 30 Day Avg. Volume: 20,822
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹72.00
• Price Target Upside: 15.24% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 52 Neutral
• Price Target: ₹72.00 ▲(15.24% Upside)

Bodal Chemicals' overall stock score is primarily influenced by its financial performance and technical analysis. The company shows strong revenue growth and operational efficiency but faces challenges with profitability and free cash flow. Technical indicators point to potential weakness in the short term. Valuation metrics suggest the stock is overvalued, impacting the overall score negatively.

Bodal Chemicals Limited Business Overview & Revenue Model

Company Description

Bodal Chemicals Limited is a prominent chemical manufacturing company headquartered in India. It operates primarily in the chemical sector, focusing on the production of dye intermediates, dyestuffs, and basic chemicals. The company's comprehensive product range serves various industries, including textiles, leather, and paper.

How the Company Makes Money

Bodal Chemicals Limited generates revenue through the manufacturing and sale of a wide array of chemical products. The company's primary revenue streams include the production and distribution of dye intermediates, which are essential components in the textile industry for dye production. Additionally, Bodal Chemicals produces dyestuffs that are used directly by textile manufacturers. The company also offers basic chemicals utilized across multiple industries, thereby diversifying its revenue base. Strategic partnerships and collaborations with key industry players further enhance its market reach and profitability. Moreover, Bodal Chemicals leverages its extensive distribution network to supply products both domestically and internationally, contributing significantly to its earnings.

Bodal Chemicals Limited Financial Statement Overview

Summary

Bodal Chemicals demonstrates positive revenue growth and improved operational efficiencies, with rising gross and EBIT margins. However, low profitability with a net profit margin of 1.06% and negative free cash flow are concerns for long-term sustainability. The balance sheet is stable with a strong equity position and manageable debt levels.

Income Statement

Bodal Chemicals has shown a mixed performance in its income statement. The company experienced a solid revenue growth rate of 25.12% from the previous year to 2025. However, its net profit margin is relatively low at 1.06%, reflecting challenges in converting revenues into profits. The gross profit margin improved significantly to 38.71% in 2025, indicating better cost management. The EBIT margin of 5.65% also shows a positive trend from prior years, suggesting operational efficiency improvements. Despite these positives, the low net profit margin remains a concern.

Balance Sheet

The balance sheet reveals a stable financial structure for Bodal Chemicals. The debt-to-equity ratio stands at 0.82, indicating a balanced approach to leveraging. The company's equity ratio of 46.94% suggests a strong equity base, although there is room for improvement. Return on equity (ROE) is low at 1.67%, highlighting inefficiencies in generating profits from equity. Overall, Bodal Chemicals maintains a stable financial position with manageable debt levels.

Cash Flow

The cash flow statement shows Bodal Chemicals facing challenges in generating free cash flow, with a negative free cash flow in 2025. The operating cash flow to net income ratio is positive at 2.06, indicating that the company generates more cash than accounting profits, which is a positive sign. However, the negative free cash flow growth rate from 2024 to 2025 reflects ongoing capital expenditure pressures. The free cash flow to net income ratio is negative, pointing to potential liquidity issues if not addressed.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2022	Dec 2022	Dec 2021
Income Statement
Total Revenue	16.88B	17.45B	13.95B	20.27B	15.74B	12.21B
Gross Profit	7.35B	6.76B	1.68B	5.42B	6.70B	3.29B
EBITDA	1.50B	1.69B	1.19B	2.18B	1.45B	1.03B
Net Income	60.39M	185.02M	64.69M	1.04B	380.33M	419.82M
Balance Sheet
Total Assets	0.00	23.53B	22.88B	21.22B	21.21B	17.48B
Cash, Cash Equivalents and Short-Term Investments	228.86M	360.60M	462.50M	93.95M	225.87M	119.14M
Total Debt	0.00	9.11B	8.47B	5.76B	6.98B	3.47B
Total Liabilities	-10.83B	12.48B	12.06B	10.70B	10.43B	7.68B
Stockholders Equity	10.83B	11.05B	10.82B	10.56B	10.78B	9.75B
Cash Flow
Free Cash Flow	0.00	-83.36M	-407.19M	-1.73B	-528.49M	-1.91B
Operating Cash Flow	0.00	381.14M	2.04B	-135.20M	2.85B	-130.17M
Investing Cash Flow	0.00	-424.34M	-2.62B	-1.70B	-3.10B	-1.68B
Financing Cash Flow	0.00	76.36M	809.81M	1.81B	326.55M	1.78B

Bodal Chemicals Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 62.48
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BODALCHEM, the sentiment is Negative. The current price of 62.48 is below the 20-day moving average (MA) of 65.52, below the 50-day MA of 68.65, and below the 200-day MA of 67.74, indicating a bearish trend. The MACD of -1.06 indicates Positive momentum. The RSI at 29.99 is Positive, neither overbought nor oversold. The STOCH value of 9.19 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BODALCHEM.

Bodal Chemicals Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AGARIND	68 Neutral	13.90B	15.49	18.45%	0.36%	3.65%	-25.64%
BHAGERIA	68 Neutral	7.76B	16.98	7.24%	0.84%	25.56%	92.57%
SHREEPUSHK	67 Neutral	14.13B	21.16	10.88%	0.46%	16.35%	55.49%
KIRIINDUS	65 Neutral	33.95B	16.64	8.15%	―	-12.76%	-17.59%
FAIRCHEMOR	54 Neutral	10.13B	109.00	7.28%	0.96%	-19.46%	-80.73%
BODALCHEM	52 Neutral	₹7.87B	26.93	―	0.17%	19.75%	845.31%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%